Otis W Brawley's Net Worth
$530 Thousand
Who is Otis W Brawley?
Otis W Brawley does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AGILENT TECHNOLOGIES, INC., INCYTE CORP, Lyell Immunopharma, Inc., PDS Biotechnology Corp, and THERAGENICS CORP.
SEC CIK
Otis W Brawley's CIK is 0001213029
Past Insider Trading and Trends
2023 was Otis W Brawley's most active year for acquiring shares with 7 total transactions. Otis W Brawley's most active month to acquire stocks was the month of May. 2004 was Otis W Brawley's most active year for disposing of shares, totalling 10 transactions. Otis W Brawley's most active month to dispose stocks was the month of January. 2024 saw Otis W Brawley paying a total of $358,081.44 for 156,775 shares, this is the most they've acquired in one year. In 2005 Otis W Brawley cashed out on 10,855 shares for a total of $42,877.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGILENT TECHNOLOGIES, INC. (A) Snapshot price: $137.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +43.15% | 2.43K |
$147.48 | $358,081.44 | 8.06K |
Mar 15
| |||
Form 4
| +75.29% | 2.4K |
$136.82 | $328,231.18 | 5.59K |
Mar 16
| |||
Form 4
| +442.20% | 2.58K |
$136.82 | $353,269.24 | 3.17K |
Mar 17
| |||
Form 4
|
∞
| 583 |
$162.16 | $94,539.28 | 583 |
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
INCYTE CORP (INCY) Snapshot price: $60.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.93% | 2.83K |
—
|
—
| 8.73K |
Jun 12
| |||
Form 4
| +73.70% | 2.5K |
—
|
—
| 5.9K |
Jun 14
| |||
Form 4
| +170.84% | 2.14K |
—
|
—
| 3.4K |
Jun 15
| |||
Form 4
|
∞
| 1.25K |
—
|
—
| 1.25K |
Sep 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Lyell Immunopharma, Inc. (LYEL) Snapshot price: $1.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PDS Biotechnology Corp (PDSB) Snapshot price: $2.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
THERAGENICS CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.13% | 5K |
—
|
—
| 40.4K |
May 17
| |||
Form 4
| +16.45% | 5K |
—
|
—
| 35.4K |
May 9
| |||
Form 4
| +19.69% | 5K |
—
|
—
| 30.39K |
May 10
| |||
Form 4
| +147.76% | 15.14K |
$2.79 | -$627.25 | 25.39K |
Jan 26
| |||
Form 4
| +10.81% | 1K |
—
|
—
| 10.25K |
Nov 10
| |||
Form 4
| +825.00% | 8.25K |
$3.62 | -$25,369.75 | 9.25K |
Feb 6 - Feb 6
| |||
Form 4
|
∞
| 1K |
—
|
—
| 1K |
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |